HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

D van der Heijde Selected Research

Back Pain (Backache)

1/2015Natural course of bone marrow oedema on magnetic resonance imaging of the sacroiliac joints in patients with early inflammatory back pain: a 2-year follow-up study.
9/2014Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.
3/2014Gadolinium contrast-enhanced MRI sequence does not have an incremental value in the assessment of sacroiliitis in patients with early inflammatory back pain by using MRI in combination with pelvic radiographs: a 2-year follow-up study.
11/2011HLA-B27 and gender independently determine the likelihood of a positive MRI of the sacroiliac joints in patients with early inflammatory back pain: a 2-year MRI follow-up study.
1/2011The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.
12/2009Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study.
6/2009New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
1/2009Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
1/2007Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic.
12/2006Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


D van der Heijde Research Topics

Disease

26Ankylosing Spondylitis
03/2015 - 07/2000
22Rheumatoid Arthritis
02/2010 - 04/2004
12Back Pain (Backache)
01/2015 - 05/2004
11Arthritis (Polyarthritis)
09/2014 - 09/2000
10Necrosis
01/2015 - 09/2002
9Inflammation
11/2011 - 09/2002
8Psoriatic Arthritis
11/2015 - 08/2006
8Pain (Aches)
01/2015 - 01/2001
6Psoriasis (Pustulosis Palmaris et Plantaris)
01/2015 - 05/2004
6Sacroiliitis
09/2014 - 05/2004
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2014 - 05/2004
5Rheumatic Diseases (Rheumatism)
01/2012 - 03/2005
3Infection
01/2014 - 09/2000
2Anterior Uveitis
09/2014 - 05/2004
2Disease Progression
02/2009 - 06/2004
2Reactive Arthritis (Reiter Disease)
09/2000 - 07/2000
1Spondylitis
09/2014
1Opportunistic Infections (Opportunistic Infection)
01/2014
1Uveitis
01/2011
1Tenosynovitis
10/2009
1Synovitis
10/2009
1Rheumatoid Nodule
11/2008
1Ankylosis
09/2008
1Spinal Diseases (Disease, Spinal)
04/2008
1Ulcerative Colitis
05/2007
1Crohn Disease (Crohn's Disease)
05/2007
1Joint Diseases (Joint Disease)
05/2006
1Spondylarthropathies
11/2005
1Fatigue
01/2005
1Osteoarthritis
11/2000
1Diarrhea
09/2000
1Autoimmune Diseases (Autoimmune Disease)
07/2000

Drug/Important Bio-Agent (IBA)

12Methotrexate (Mexate)FDA LinkGeneric
07/2009 - 04/2004
11TNFR-Fc fusion protein (etanercept)FDA Link
01/2014 - 09/2002
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009 - 09/2002
10infliximab (Remicade)FDA Link
02/2009 - 09/2002
8CDP870FDA Link
11/2015 - 06/2009
8O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
01/2015 - 05/2004
6Antirheumatic Agents (DMARD)IBA
01/2012 - 01/2009
6C-Reactive ProteinIBA
01/2010 - 11/2004
5AntibodiesIBA
02/2010 - 09/2000
4ametantrone (HAQ)IBA
01/2015 - 01/2005
4Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2014 - 09/2003
4HLA-B27 Antigen (HLA B27 Antigen)IBA
11/2011 - 07/2000
4Biological Markers (Surrogate Marker)IBA
01/2010 - 04/2008
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2006 - 08/2001
3Gadolinium DTPA (Magnevist)FDA Link
03/2014 - 11/2002
3GadoliniumIBA
03/2014 - 09/2002
3cyclic citrullinated peptideIBA
01/2010 - 02/2008
3amsonic acid (DAS)IBA
02/2008 - 11/2005
2AntigensIBA
01/2011 - 03/2008
2Immunoglobulin A (IgA)IBA
01/2010 - 11/2008
2Rheumatoid FactorIBA
01/2010 - 11/2008
2Immunoglobulin M (IgM)IBA
01/2010 - 11/2008
2adalimumab (Humira)FDA Link
06/2009 - 09/2008
2protein-arginine deiminaseIBA
02/2009 - 03/2008
2Immunoglobulin G (IgG)IBA
02/2009 - 03/2008
2TEMPOIBA
12/2007 - 03/2006
2SteroidsIBA
03/2006 - 09/2003
1Inosine Monophosphate (IMP)IBA
09/2014
1acetyl 4-aminosalicylic acidIBA
02/2010
1VimentinIBA
02/2010
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2010
1tebufenozide (Mimic)IBA
10/2009
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2009
1Prednisolone (Predate)FDA LinkGeneric
04/2009
1EpitopesIBA
02/2009
1HLA-DRB1 antigen (HLA DRB1)IBA
11/2008
1Interleukin-6 (Interleukin 6)IBA
04/2008
1Aligeron (AS 2)IBA
12/2006
1Naproxen (Naprosyn)FDA LinkGeneric
11/2005
1Carbon MonoxideIBA
11/2005
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2005
1etoricoxibIBA
11/2005
1leflunomide (Arava)FDA LinkGeneric
06/2004
1Acute-Phase Proteins (Acute-Phase Protein)IBA
09/2003
1Pentetic Acid (DTPA)FDA LinkGeneric
09/2002
1Ketoprofen (Orudis)FDA LinkGeneric
01/2001
1celecoxib (Celebrex)FDA Link
01/2001
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2001
1rofecoxib (Vioxx)FDA Link
11/2000
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2000
1Anti-Bacterial Agents (Antibiotics)IBA
07/2000

Therapy/Procedure

3Aftercare (After-Treatment)
04/2008 - 05/2004
2Biological Therapy
03/2005 - 09/2003
1Perioperative Period
07/2009
1Withholding Treatment
02/2006
1Hip Replacement Arthroplasty (Total Hip Replacement)
11/2001
1Exercise Therapy (Therapy, Exercise)
10/2001